General - Press Releases

Date	Title	Company
09-Jun-2023	Vertex Presents Data Demonstrating Significant Benefits of Long-Term Treatment With CFTR Modulators at the European Cystic Fibrosis Conference	Businesswire
09-Jun-2023	Rallybio to Present Data from the RLYB212 Phase 1b Proof-of-Concept Study at the 31st Congress of the International Society on Thrombosis and Haemostasis	Businesswire
09-Jun-2023	US Pharma Packaging Market Insights 2023-2028 Featuring Amcor, Aptar Group, Berry Global, Laser Gerresheimer, and WestRock - ResearchAndMarkets.com	Businesswire
09-Jun-2023	New Data Show Genentech’s Subcutaneously Administered Crovalimab Achieved Disease Control and Was Well-Tolerated in People With Paroxysmal Nocturnal Hemoglobinuria (PNH)	Businesswire
09-Jun-2023	World Next-Generation Optical Fiber (Multicore and Hollow Core Fiber) Market Analysis and Forecasts, 2022-2023 & 2031 - ResearchAndMarkets.com	Businesswire
09-Jun-2023	TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology	Businesswire
09-Jun-2023	Baron & Budd Obtains Record $500 Million Settlement Against Walgreens in New Mexico AG Opioid Suit	Businesswire
09-Jun-2023	Asia-Pacific Vaccine Packaging Market Report 2023: A $1.149 Billion Market by 2028 from $695 Million in 2022 with China Dominating - ResearchAndMarkets.com	Businesswire
09-Jun-2023	Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com	Businesswire
09-Jun-2023	Invibio, Part of Victrex plc, Announces New Collaboration With Paragon Medical to Support Scale Up of PEEK Based Trauma Devices	Businesswire
09-Jun-2023	Manchester-based pharmaceutical company, Chiesi Ltd, tackles food waste and poverty on annual We ACT Day	Chiesi Ltd
09-Jun-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
09-Jun-2023	BeiGene Highlights Promising Data from Blood Cancer Portfolio and Pipeline at the European Hematology Association Hybrid Congress	Businesswire
09-Jun-2023	Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association (EHA) Congress	Businesswire
09-Jun-2023	Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas at European Hematology Association (EHA) Annual Meeting 2023	Businesswire
09-Jun-2023	Wugen Presents Initial Data from First-in-Human Phase 1/2 Trial of WU-CART-007 at the European Hematology Association (EHA) 2023 Congress	Businesswire
09-Jun-2023	Advicenne announces the approval of all resolutions supported by the Board of Directors at its Combined General Meeting	Businesswire
09-Jun-2023	Fate ALERT: Bragar Eagel & Squire, P.C. is Investigating Fate Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	Businesswire
09-Jun-2023	MediPrint® Ophthalmics Announces Promising Results from Its SIGHT-2 Phase 2b Group 1 Clinical Study	Businesswire
09-Jun-2023	FDA Accepts Biologics License Applications for exagamglogene autotemcel (exa-cel) for Severe Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia	Businesswire